Congenital Cytomegalovirus-Related Hearing Loss.
Nicoleta GanaIulia HuluțăMihai-Ștefan CătănescuLivia-Mihaela ApostolFlorina Mihaela NedeleaRomina-Marina SimaRadu BotezatuAnca Maria PanaitescuDiana Antonia IordachescuPublished in: Audiology research (2024)
Congenital hearing loss is a significant global health concern that affects millions of newborns and infants worldwide, posing substantial challenges for affected individuals, their families, and healthcare systems. This condition, present at birth, can stem from genetic factors, in utero exposures, infections, or complications during pregnancy or childbirth. The spectrum of congenital hearing loss ranges from mild to profound, impacting the development of speech, language, and cognitive skills, thereby influencing educational achievements, social integration, and future employment opportunities. Early detection and intervention strategies, such as newborn hearing screenings, genetic counseling, and the use of hearing aids or cochlear implants, are crucial for mitigating these impacts. This review article aims to explore the diagnostic approaches and management strategies for congenital cytomegalovirus-related hearing loss, emphasizing the importance of interdisciplinary care and the potential for technological advances to improve outcomes for affected individuals.
Keyphrases
- hearing loss
- healthcare
- global health
- randomized controlled trial
- epstein barr virus
- public health
- pregnant women
- palliative care
- copy number
- mental health
- risk factors
- smoking cessation
- gene expression
- quality improvement
- hepatitis c virus
- pain management
- preterm infants
- insulin resistance
- metabolic syndrome
- cord blood
- drug induced
- skeletal muscle
- glycemic control
- hiv testing